Suppr超能文献

用 CMaxSPRT 分析历史数据和监测泊松数据的 Alpha 花费。

Alpha spending for historical versus surveillance Poisson data with CMaxSPRT.

机构信息

Department of Statistics, Federal University of Ouro Preto, Brazil.

Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts.

出版信息

Stat Med. 2019 May 30;38(12):2126-2138. doi: 10.1002/sim.8097. Epub 2019 Jan 28.

Abstract

Sequential analysis hypothesis testing is now an important tool for postmarket drug and vaccine safety surveillance. When the number of adverse events accruing in time is assumed to follow a Poisson distribution, and if the baseline Poisson rate is assessed only with uncertainty, the conditional maximized sequential probability ratio test, CMaxSPRT, is a formal solution. CMaxSPRT is based on comparing monitored data with historical matched data, and it was primarily developed under a flat signaling threshold. This paper demonstrates that CMaxSPRT can be performed under nonflat thresholds too. We pose the discussion in the light of the alpha spending approach. In addition, we offer a rule of thumb for establishing the best shape of the signaling threshold in the sense of minimizing expected time to signal and expected sample size. An example involving surveillance for adverse events after influenza vaccination is used to illustrate the method.

摘要

序贯分析假设检验现在是药品和疫苗上市后安全性监测的重要工具。当累积的不良事件数量随时间呈泊松分布,并且仅对基线泊松率进行不确定评估时,条件最大化序贯概率比检验(CMaxSPRT)是一种正式的解决方案。CMaxSPRT 基于比较监测数据与历史匹配数据,主要是在平坦信号阈值下开发的。本文证明了 CMaxSPRT 也可以在非平坦阈值下进行。我们根据 α 支出方法进行讨论。此外,我们还提供了一种经验法则,用于确定信号阈值的最佳形状,以最小化信号时间和样本量的期望。一个涉及流感疫苗接种后不良事件监测的示例用于说明该方法。

相似文献

1
Alpha spending for historical versus surveillance Poisson data with CMaxSPRT.
Stat Med. 2019 May 30;38(12):2126-2138. doi: 10.1002/sim.8097. Epub 2019 Jan 28.
2
A conditional maximized sequential probability ratio test for pharmacovigilance.
Stat Med. 2010 Jan 30;29(2):284-95. doi: 10.1002/sim.3780.
3
Implementing near real-time vaccine safety surveillance using the Clinical Practice Research Datalink (CPRD).
Vaccine. 2017 Dec 14;35(49 Pt B):6885-6892. doi: 10.1016/j.vaccine.2017.09.022. Epub 2017 Oct 19.
4
Near real-time vaccine safety surveillance with partially accrued data.
Pharmacoepidemiol Drug Saf. 2011 Jun;20(6):583-90. doi: 10.1002/pds.2133.
5
Exact conditional maximized sequential probability ratio test adjusted for covariates.
Seq Anal. 2019;38(1):115-133. doi: 10.1080/07474946.2019.1574446. Epub 2019 May 13.
6
Post licensure surveillance of influenza vaccines in the Vaccine Safety Datalink in the 2013-2014 and 2014-2015 seasons.
Pharmacoepidemiol Drug Saf. 2016 Aug;25(8):928-34. doi: 10.1002/pds.3996. Epub 2016 Apr 1.
8
The person-time ratio distribution for the exact monitoring of adverse events: Historical vs surveillance Poisson data.
Stat Med. 2023 Aug 15;42(18):3283-3301. doi: 10.1002/sim.9805. Epub 2023 May 23.
9
Type I error probability spending for post-market drug and vaccine safety surveillance with binomial data.
Stat Med. 2018 Jan 15;37(1):107-118. doi: 10.1002/sim.7504. Epub 2017 Sep 25.
10
Continuous sequential boundaries for vaccine safety surveillance.
Stat Med. 2014 Aug 30;33(19):3387-97. doi: 10.1002/sim.6161. Epub 2014 Apr 1.

引用本文的文献

本文引用的文献

1
Exact conditional maximized sequential probability ratio test adjusted for covariates.
Seq Anal. 2019;38(1):115-133. doi: 10.1080/07474946.2019.1574446. Epub 2019 May 13.
2
Type I Error Probability Spending for Post-Market Drug and Vaccine Safety Surveillance With Poisson Data.
Methodol Comput Appl Probab. 2018 Jun;20(2):739-750. doi: 10.1007/s11009-017-9586-z. Epub 2017 Aug 3.
3
Type I error probability spending for post-market drug and vaccine safety surveillance with binomial data.
Stat Med. 2018 Jan 15;37(1):107-118. doi: 10.1002/sim.7504. Epub 2017 Sep 25.
4
5
Prospective influenza vaccine safety surveillance using fresh data in the Sentinel System.
Pharmacoepidemiol Drug Saf. 2016 May;25(5):481-92. doi: 10.1002/pds.3908. Epub 2015 Nov 17.
6
Febrile Seizures After 2010-2011 Trivalent Inactivated Influenza Vaccine.
Pediatrics. 2015 Oct;136(4):e848-55. doi: 10.1542/peds.2015-0635. Epub 2015 Sep 14.
7
Continuous versus group sequential analysis for post-market drug and vaccine safety surveillance.
Biometrics. 2015 Sep;71(3):851-8. doi: 10.1111/biom.12324. Epub 2015 May 22.
8
Measles-mumps-rubella-varicella combination vaccine and the risk of febrile seizures.
Pediatrics. 2010 Jul;126(1):e1-8. doi: 10.1542/peds.2010-0665. Epub 2010 Jun 29.
9
A conditional maximized sequential probability ratio test for pharmacovigilance.
Stat Med. 2010 Jan 30;29(2):284-95. doi: 10.1002/sim.3780.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验